Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biogaia Adr Class B BIOGY

Healthcare Biotechnology
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics... see more

Recent & Breaking News (PINL:BIOGY)

Research and Markets: Oncology Pharmaceuticals Market in India 2014

Business Wire January 7, 2015

AVEO Announces Executive Transition and Corporate Restructuring

Business Wire January 7, 2015

Affimed Receives EUR 2.4 million ($3 million) Research Grant from German Government to Fund Trispecific Abs

GlobeNewswire January 7, 2015

Evotec and Padlock Therapeutics Announce Initial Success and Extension of Long-Term Collaboration

GlobeNewswire January 7, 2015

Genomic Vision Achieves Major Milestone with Delivery of New High-Throughput Genome Analyzer to Quest Diagnostics

Business Wire January 7, 2015

Caribou Biosciences Announces New Research Collaboration and Equity Investment Agreements with Novartis

Business Wire January 7, 2015

Novartis collaborates with Intellia Therapeutics and Caribou Biosciences to explore making medicines and drug discovery tools with CRISPR genome editing technology

Thomson Reuters ONE January 7, 2015

HP Selects Intel to Power HP Multi Jet Fusion Technology

Marketwired January 6, 2015

21st Century Oncology Announces Acquisition of Northwest Cancer Clinic

GlobeNewswire January 6, 2015

KaloBios Reports Top-Line Data for Phase 2 Study of KB001-A to Treat Pseudomonas Aeruginosa Lung Infections in Cystic Fibrosis Patients

PR Newswire January 6, 2015

Meditope Biosciences Enhances Leadership Team With New Executive And Board Appointments

PR Newswire January 6, 2015

Avi-on Labs Transforms Homes and Offices With Simple Bluetooth Lighting Ecosystem

PR Newswire January 6, 2015

StemBioSys Inc. to Present at Biotech Showcase(TM) 2015

Business Wire January 6, 2015

Arizona DNA Advocacy Project Receives Almost $1M Grant From DOJ

PR Newswire January 6, 2015

Biomatrica Announces Patent Award for Novel Method of Stabilizing and Storing Biological Materials to Improve Downstream Testing

PR Newswire January 6, 2015

Warren Ribley Named President & CEO of iBIO and the iBIO Institute

Business Wire January 6, 2015

David Mittelman, Ph.D., Geneticist and Informatics Expert, Joins Tute Genomics as Chief Scientific Officer

PR Newswire January 6, 2015

Cellectis Announces the Issuance by the USPTO of a Patent Covering a Seminal Nuclease-Based "gene editing" Method

Business Wire January 6, 2015

The Pre-Filled Syringes Market: 2015 - 2030 - Opportunities, Challenges, Strategies & Forecasts

PR Newswire January 6, 2015

New Molecular Diagnostic Methods Could Reduce Risk of Miscarriage in Prenatal Testing for Genetic Diseases

PR Newswire January 6, 2015